LT3195875T - Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai - Google Patents

Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Info

Publication number
LT3195875T
LT3195875T LTEP17154031.3T LT17154031T LT3195875T LT 3195875 T LT3195875 T LT 3195875T LT 17154031 T LT17154031 T LT 17154031T LT 3195875 T LT3195875 T LT 3195875T
Authority
LT
Lithuania
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
LTEP17154031.3T
Other languages
English (en)
Inventor
Joan-Carles Arce
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3195875(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of LT3195875T publication Critical patent/LT3195875T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LTEP17154031.3T 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai LT3195875T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
LT3195875T true LT3195875T (lt) 2018-11-12

Family

ID=46785372

Family Applications (7)

Application Number Title Priority Date Filing Date
LTEP21207717.6T LT4005588T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP14184409.2T LT2821080T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP18167552.1T LT3395357T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP20186935.1T LT3756681T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19213649.7T LT3646881T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19164277.6T LT3566712T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP17154031.3T LT3195875T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Family Applications Before (6)

Application Number Title Priority Date Filing Date
LTEP21207717.6T LT4005588T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP14184409.2T LT2821080T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP18167552.1T LT3395357T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP20186935.1T LT3756681T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19213649.7T LT3646881T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19164277.6T LT3566712T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Country Status (31)

Country Link
US (4) US9694052B2 (lt)
EP (9) EP3646881B1 (lt)
JP (5) JP6161609B2 (lt)
KR (7) KR102014469B1 (lt)
CN (2) CN107281470A (lt)
AR (1) AR087476A1 (lt)
AU (3) AU2012293647B2 (lt)
BR (2) BR112014002884A2 (lt)
CA (1) CA2844282A1 (lt)
CY (1) CY1117214T1 (lt)
DK (8) DK3756681T3 (lt)
ES (7) ES2562648T3 (lt)
FI (2) FI4005588T3 (lt)
HK (2) HK1198005A1 (lt)
HR (7) HRP20230607T1 (lt)
HU (7) HUE062640T2 (lt)
IL (2) IL300380A (lt)
JO (1) JO3092B1 (lt)
LT (7) LT4005588T (lt)
MX (2) MX348981B (lt)
PL (7) PL2821080T3 (lt)
PT (6) PT2821080T (lt)
RS (7) RS61672B1 (lt)
RU (2) RU2613324C3 (lt)
SA (1) SA112330762B1 (lt)
SI (7) SI2741763T1 (lt)
SM (1) SMT201600038B (lt)
TR (2) TR201900071T4 (lt)
TW (2) TWI555530B (lt)
WO (1) WO2013020996A1 (lt)
ZA (2) ZA201400952B (lt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
DK3662925T3 (da) * 2015-04-17 2021-06-28 Ferring Bv Sammensætning, der omfatter fsh, til behandling af infertilitet
RU2719468C2 (ru) 2015-06-26 2020-04-17 Ферринг Б.В. Способы очистки и/или вирусной инактивации
AU2016323541A1 (en) * 2015-09-17 2018-04-12 Glycotope Gmbh Mammalian follicle-stimulating hormone composition with increased stability
WO2018060438A1 (en) * 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating female infertility
MX2020002235A (es) * 2017-09-01 2020-07-20 Ferring Bv Composicion para la estimulacion ovarica controlada.
TW201945024A (zh) 2018-04-30 2019-12-01 荷蘭商菲林公司 用於經控制之卵巢刺激的組成物
TW202027780A (zh) 2018-10-17 2020-08-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
MEP38608A (en) * 2001-10-22 2011-02-10 Merck Serono Sa Gonadotrophins for folliculogenesis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
ES2547233T5 (es) * 2010-09-29 2024-03-27 Ferring Bv Composición para su uso en el tratamiento de la esterilidad
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
HRP20230607T1 (hr) 2023-09-29
EP2741763B1 (en) 2015-11-18
IL300380A (en) 2023-04-01
IL230696A0 (en) 2014-03-31
RU2014102924A (ru) 2015-09-20
EP4306174A2 (en) 2024-01-17
EP3566712A1 (en) 2019-11-13
CY1117214T1 (el) 2017-04-05
KR20190100449A (ko) 2019-08-28
KR102111514B1 (ko) 2020-05-18
HUE040058T2 (hu) 2019-02-28
JP2017141253A (ja) 2017-08-17
CN103732243A (zh) 2014-04-16
RU2613324C3 (ru) 2021-06-09
JP6161609B2 (ja) 2017-07-12
PL3395357T3 (pl) 2019-11-29
TW201309322A (zh) 2013-03-01
PL3646881T3 (pl) 2021-11-02
ZA201400952B (en) 2022-03-30
HUE062640T2 (hu) 2023-11-28
JP2020147600A (ja) 2020-09-17
US20180028620A1 (en) 2018-02-01
PL2821080T3 (pl) 2019-04-30
KR20210143934A (ko) 2021-11-29
ES2692774T3 (es) 2018-12-05
EP3646881B1 (en) 2021-04-28
JP6718951B2 (ja) 2020-07-08
BR122020001644B1 (pt) 2022-08-02
LT3395357T (lt) 2019-08-26
KR20200121918A (ko) 2020-10-26
IL230696B2 (en) 2023-07-01
HRP20190023T1 (hr) 2019-02-22
AU2016273925A1 (en) 2017-01-12
DK3395357T3 (da) 2019-08-19
RU2017106756A (ru) 2019-01-23
US20200345814A1 (en) 2020-11-05
DK2821080T3 (en) 2019-01-28
US20140329748A1 (en) 2014-11-06
CN107281470A (zh) 2017-10-24
WO2013020996A1 (en) 2013-02-14
AU2018203222A1 (en) 2018-05-24
HUE044610T2 (hu) 2019-11-28
TR201900071T4 (tr) 2019-01-21
AU2012293647A1 (en) 2014-02-27
HK1198005A1 (zh) 2015-03-06
JP6500050B2 (ja) 2019-04-10
PT3756681T (pt) 2023-07-25
HRP20191437T1 (hr) 2019-11-15
EP4306174A3 (en) 2024-04-10
JP2019077693A (ja) 2019-05-23
KR20230024442A (ko) 2023-02-20
NZ620369A (en) 2015-12-24
ES2884947T3 (es) 2021-12-13
JP2023134561A (ja) 2023-09-27
TWI657822B (zh) 2019-05-01
KR102014469B1 (ko) 2019-08-26
LT3566712T (lt) 2021-03-10
TR201911269T4 (tr) 2019-08-21
AU2016273925B2 (en) 2018-03-15
LT2821080T (lt) 2019-01-10
EP3646881A1 (en) 2020-05-06
HRP20160145T1 (hr) 2016-04-08
RS57897B1 (sr) 2019-01-31
SI2821080T1 (sl) 2019-01-31
RS61843B1 (sr) 2021-06-30
IL230696B1 (en) 2023-03-01
DK2741763T3 (da) 2016-02-15
US9694052B2 (en) 2017-07-04
CA2844282A1 (en) 2013-02-14
EP3756681B1 (en) 2023-05-03
SI2741763T1 (sl) 2016-02-29
HRP20210277T1 (hr) 2021-04-02
TWI555530B (zh) 2016-11-01
HUE053716T2 (hu) 2021-07-28
ES2742163T3 (es) 2020-02-13
SI3395357T1 (sl) 2019-09-30
RS54561B1 (en) 2016-06-30
PT3646881T (pt) 2021-06-02
RU2739037C3 (ru) 2021-09-08
KR20210099162A (ko) 2021-08-11
ZA201506382B (en) 2017-01-25
ES2950911T3 (es) 2023-10-16
EP2821080A1 (en) 2015-01-07
HK1204923A1 (en) 2015-12-11
KR20190140098A (ko) 2019-12-18
SI3756681T1 (sl) 2023-08-31
DK3756681T3 (da) 2023-07-31
US10624953B2 (en) 2020-04-21
AU2012293647B2 (en) 2016-10-06
ES2562648T3 (es) 2016-03-07
KR102353144B1 (ko) 2022-01-18
SI3566712T1 (sl) 2021-04-30
EP3195875A1 (en) 2017-07-26
AR087476A1 (es) 2014-03-26
JP2014522871A (ja) 2014-09-08
HUE027674T2 (en) 2016-11-28
SA112330762B1 (ar) 2015-10-08
KR20140054191A (ko) 2014-05-08
LT3646881T (lt) 2021-05-25
RS58198B1 (sr) 2019-03-29
HUE041769T2 (hu) 2019-05-28
RU2739037C2 (ru) 2020-12-21
PT3195875T (pt) 2018-10-31
DK3195875T3 (en) 2018-11-12
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
AU2018203222B2 (en) 2020-03-12
JO3092B1 (ar) 2017-03-15
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
EP3395357A1 (en) 2018-10-31
SMT201600038B (it) 2016-02-25
EP3395357B1 (en) 2019-05-15
PL2741763T3 (pl) 2016-07-29
EP3195875B1 (en) 2018-07-25
HRP20210722T1 (hr) 2021-06-11
DK3646881T3 (da) 2021-07-26
RS59107B1 (sr) 2019-09-30
PL3566712T3 (pl) 2021-07-12
JP7309660B2 (ja) 2023-07-18
TW201716082A (zh) 2017-05-16
EP3566712B1 (en) 2021-01-27
DK4005588T3 (da) 2024-04-29
ES2704878T3 (es) 2019-03-20
PT2821080T (pt) 2018-12-17
RU2017106756A3 (lt) 2020-07-09
US20220370567A1 (en) 2022-11-24
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
SI3646881T1 (sl) 2021-08-31
ES2871405T3 (es) 2021-10-28
KR102499969B1 (ko) 2023-02-14
DK3566712T3 (da) 2021-04-19
PT3395357T (pt) 2019-08-27
EP4005588A1 (en) 2022-06-01
EP4005588B1 (en) 2024-02-07
FI4005588T3 (fi) 2024-05-15
BR112014002884A2 (pt) 2017-02-21
MX348981B (es) 2017-07-06
MX2014001489A (es) 2014-04-25
RS61672B1 (sr) 2021-04-29
RS64328B1 (sr) 2023-08-31
MX2020010991A (es) 2020-11-09
EP3756681A1 (en) 2020-12-30
FI3756681T3 (fi) 2023-07-28
HRP20181639T1 (hr) 2018-12-14
LT3756681T (lt) 2023-07-25
HUE054312T2 (hu) 2021-08-30
RU2613324C2 (ru) 2017-03-15
PL3195875T3 (pl) 2019-01-31
PL3756681T3 (pl) 2023-08-21

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
PT3566712T (pt) Composição para estimulação controlada do ovário